These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 6218927
1. Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. Tin F, Hlaing N, Lasserre R. Bull World Health Organ; 1982; 60(6):913-7. PubMed ID: 6218927 [Abstract] [Full Text] [Related]
2. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma. Tin F, Hlaing N, Tun T, Win S, Lasserre R. Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320 [Abstract] [Full Text] [Related]
3. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Harinasuta T, Bunnag D, Wernsdorfer WH. Bull World Health Organ; 1983; 61(2):299-305. PubMed ID: 6345013 [Abstract] [Full Text] [Related]
4. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria. Botero D, Restrepo M, Montoya A. Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296 [Abstract] [Full Text] [Related]
5. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. de Souza JM, Sheth UK, de Oliveira RM, Roulet H, de Souza SD. Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397 [Abstract] [Full Text] [Related]
6. Comparative drug trial of a sulfadoxine/pyrimethamine and a sulfalene/pyrimethamine combination against Plasmodium falciparum infections in semi-immune populations of Burma. Tin F, Nyunt-Hlaing. Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):238-48. PubMed ID: 6239381 [Abstract] [Full Text] [Related]
7. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB. Bull World Health Organ; 1987 Jun; 65(3):357-61. PubMed ID: 3311438 [Abstract] [Full Text] [Related]
8. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM, Phiri DE, Sheth UK, Mukunyandela M. Bull World Health Organ; 1987 Jun; 65(3):369-73. PubMed ID: 3311440 [Abstract] [Full Text] [Related]
9. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. Ekue JM, Simooya OO, Sheth UK, Wernsdorfer WH, Njelesani EK. Bull World Health Organ; 1985 Jun; 63(2):339-43. PubMed ID: 3893778 [Abstract] [Full Text] [Related]
11. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. de Souza JM, Sheth UK, de Oliveira RM, Gomes AT, Cavalcante EQ. Bull World Health Organ; 1985 Jun; 63(3):611-5. PubMed ID: 3899398 [Abstract] [Full Text] [Related]
12. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. Boudreau EF, Pang LW, Dixon KE, Webster HK, Pavanand K, Tosingha L, Somutsakorn P, Canfield CJ. Bull World Health Organ; 1988 Jun; 66(2):227-35. PubMed ID: 3293828 [Abstract] [Full Text] [Related]
13. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. Kofi Ekue JM, Ulrich AM, Rwabwogo-Atenyi J, Sheth UK. Bull World Health Organ; 1983 Jun; 61(4):713-8. PubMed ID: 6354507 [Abstract] [Full Text] [Related]
14. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. Chongsuphajaisiddhi T, Sabchareon A, Chantavanich P, Singhasivanon V, Attanath P, Wernsdorfer WH, Sheth UK. Bull World Health Organ; 1987 Jun; 65(2):223-6. PubMed ID: 3301042 [Abstract] [Full Text] [Related]
15. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar. Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ. Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314 [Abstract] [Full Text] [Related]
16. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria. Fadeke Aderounmu A, Salako LA, Laoye AJ, Modupe Makinde J, Aina Adio R. Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365 [Abstract] [Full Text] [Related]
17. Response of falciparum malaria to different antimalarials in Myanmar. Ejov MN, Tun T, Aung S, Sein K. Bull World Health Organ; 1999 Dec; 77(3):244-9. PubMed ID: 10212515 [Abstract] [Full Text] [Related]
18. Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma. Tin F, Nyunt Hlaing, Lim MA, Win S, Lasserre R. Trans R Soc Trop Med Hyg; 1987 Dec; 81(6):910-2. PubMed ID: 3332509 [Abstract] [Full Text] [Related]
19. A phase II clinical trial of mefloquine in Brazilian male subjects. de Souza JM. Bull World Health Organ; 1983 Dec; 61(5):815-20. PubMed ID: 6360401 [Abstract] [Full Text] [Related]
20. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Slutsker LM, Khoromana CO, Payne D, Allen CR, Wirima JJ, Heymann DL, Patchen L, Steketee RW. Bull World Health Organ; 1990 Dec; 68(1):53-9. PubMed ID: 2189586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]